Filippo Pelizzaro

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Ejection Fraction

Monoclonal Antibody

Radiofrequency Ablation

Top Venues

Journal of clinical medicine

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Zanatta, Elisabetta Patron, Simone Messerotti Benvenuti, Filippo Pelizzaro, Francesco Paolo Russo, Martina Gambato, Giacomo Germani, Alberto Ferrarese, Alberto Zanetto, Federica Battermann, Francesca Buccheri, Chiara Cavalli, Rossana Schiavo, Marta Ghisi, Sara Pasquato, Paolo Feltracco, Umberto Cillo, Patrizia Burra, Marco Senzolo
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates. Journal of clinical medicine 13 (13) (2024)
Elisa Zanatta, Elisabetta Patron, Simone Messerotti Benvenuti, Filippo Pelizzaro, Francesco Paolo Russo, Martina Gambato, Giacomo Germani, Alberto Ferrarese, Alberto Zanetto, Federica Battermann, Francesca Buccheri, Chiara Cavalli, Rossana Schiavo, Marta Ghisi, Sara Pasquato, Paolo Feltracco, Umberto Cillo, Patrizia Burra, Marco Senzolo
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates. Journal of clinical medicine 13 (13) (2024)
Filippo Pelizzaro, Fabio Farinati, Franco Trevisani
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance. Biomedicines 11 (4) (2023)
Elisa Pinto, Filippo Pelizzaro, Fabio Farinati, Francesco Paolo Russo
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Filippo Pelizzaro, Fabio Farinati, Franco Trevisani
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance. Biomedicines 11 (4) (2023)
Elisa Pinto, Filippo Pelizzaro, Fabio Farinati, Francesco Paolo Russo
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Filippo Pelizzaro, Franco Trevisani, Vittorio Simeon, Alessandro Vitale, Umberto Cillo, Piscaglia Fabio, Gabriele Missale, Angelo Sangiovanni, Francesco G Foschi, Giuseppe Cabibbo, Eugenio Caturelli, Maria Di Marco, Francesco Azzaroli, Maurizia Rossana Brunetto, Giovanni Raimondo, Gianpaolo Vidili, Maria Guarino, Antonio Gasbarrini, Claudia Campani, Gianluca Svegliati-Baroni, Edoardo Giovanni Giannini, Andrea Mega, Alberto Masotto, Gian Ludovico Rapaccini, Donatella Magalotti, Rodolfo Sacco, Gerardo Nardone, Fabio Farinati, null null
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection. Liver international : official journal of the International Association for the Study of the Liver (2023)
Elisa Pinto, Filippo Pelizzaro, Fabio Farinati, Francesco Paolo Russo
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Luca Marzi, Andrea Mega, Stefano Gitto, Filippo Pelizzaro, Andreas Seeber, Gilbert Spizzo
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC. Cancers 14 (14) (2022)
Giovanni Marasco, Francesco Poggioli, Antonio Colecchia, Giuseppe Cabibbo, Filippo Pelizzaro, Edoardo Giovanni Giannini, Sara Marinelli, Gian Ludovico Rapaccini, Eugenio Caturelli, Mariella Di Marco, Elisabetta Biasini, Fabio Marra, Filomena Morisco, Francesco Giuseppe Foschi, Marco Zoli, Antonio Gasbarrini, Gianluca Svegliati Baroni, Alberto Masotto, Rodolfo Sacco, Giovanni Raimondo, Francesco Azzaroli, Andrea Mega, Gianpaolo Vidili, Maurizia Rossana Brunetto, Gerardo Nardone, Luigina Vanessa Alemanni, Elton Dajti, Federico Ravaioli, Davide Festi, Franco Trevisani, On Behalf Of The Italian Liver Cancer Ita Li Ca Group
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study. Cancers 13 (11) (2021)
Filippo Pelizzaro, Ilaria Marsilio, Angelo Paolo Dei Tos, Francesco A Piazza, Brigida Barberio, Anna D'Odorico, Edoardo Vincenzo Savarino, Fabio Farinati, Fabiana Zingone
The Risk of Malignancies in Celiac Disease-A Literature Review. Cancers 13 (21) (2021)
Filippo Pelizzaro, Barbara Penzo, Franco Trevisani, Fabio Farinati, null null
Letter: is female sex really associated with better prognosis in hepatocellular carcinoma? Alimentary pharmacology & therapeutics 53 (5) (2021)
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Fabio Farinati
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now? Cancers 13 (9) (2021)
Filippo Pelizzaro, Romilda Cardin, Anna Sartori, Angela Imondi, Barbara Penzo, Camillo Aliberti, Alberto Ponzoni, Alessandro Vitale, Umberto Cillo, Fabio Farinati
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines 9 (8) (2021)
Filippo Pelizzaro, Martina Gambato, Enrico Gringeri, Alessandro Vitale, Umberto Cillo, Fabio Farinati, Patrizia Burra, Francesco Paolo Russo
Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 13 (19) (2021)
Filippo Pelizzaro, Maria Piera Kitenge, Romilda Cardin, Alberto Ponzoni, Umberto Cillo, Alessandro Vitale, Gianluca Businello, Giada Munari, Angelo Paolo Dei Tos, Fabio Farinati
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma. Clinical and experimental medicine 21 (4) (2021)
Maria Corina Plaz Torres, Quirino Lai, Piscaglia Fabio, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, Edoardo Giovanni Giannini
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. Journal of clinical medicine 10 (15) (2021)
Filippo Pelizzaro, Alessandro Vitale, Anna Sartori, Andrea Vieno, Barbara Penzo, Francesco Paolo Russo, Anna Chiara Frigo, Edoardo Giovanni Giannini, Manuela Piccinnu, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Ciro Celsa, Fabio Marra, Andrea Mega, Maria Guarino, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Andrea Olivani, Alberto Masotto, Pietro Coccoli, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Maurizia Rossana Brunetto, Franco Trevisani, Fabio Farinati, null On Behalf Of Ita Li Ca Study Group
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients. Cancers 13 (4) (2021)
Filippo Pelizzaro, Federica Soldà, Romilda Cardin, Angela Imondi, Anna Sartori, Barbara Penzo, Ambra Sammarco, Camillo Aliberti, Alessandro Vitale, Umberto Cillo, Fabio Farinati
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences. Biomarkers in medicine 14 (10) (2020)